GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tourmaline Bio Inc (NAS:TRML) » Definitions » FCF Yield %

Tourmaline Bio (Tourmaline Bio) FCF Yield % : -7.35 (As of May. 13, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Tourmaline Bio FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Tourmaline Bio's Trailing 12-Month Free Cash Flow is $-28.14 Mil, and Market Cap is $382.90 Mil. Therefore, Tourmaline Bio's FCF Yield % for today is -7.35%.

The historical rank and industry rank for Tourmaline Bio's FCF Yield % or its related term are showing as below:

TRML' s FCF Yield % Range Over the Past 10 Years
Min: -7.61   Med: 0   Max: 0
Current: -7.35

TRML's FCF Yield % is ranked better than
63.34% of 1555 companies
in the Biotechnology industry
Industry Median: -14.28 vs TRML: -7.35

Tourmaline Bio's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

Tourmaline Bio FCF Yield % Historical Data

The historical data trend for Tourmaline Bio's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tourmaline Bio FCF Yield % Chart

Tourmaline Bio Annual Data
Trend Dec21 Dec22 Dec23
FCF Yield %
- - -5.28

Tourmaline Bio Quarterly Data
Dec21 Jun22 Sep22 Dec22 Jun23 Sep23 Dec23
FCF Yield % Get a 7-Day Free Trial - - - - -

Competitive Comparison of Tourmaline Bio's FCF Yield %

For the Biotechnology subindustry, Tourmaline Bio's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tourmaline Bio's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Tourmaline Bio's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Tourmaline Bio's FCF Yield % falls into.


Tourmaline Bio FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Tourmaline Bio's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-28.137 / 532.438368
=-5.28%

Tourmaline Bio's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=0 * 4 / 532.438368
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tourmaline Bio FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Tourmaline Bio FCF Yield % Related Terms

Thank you for viewing the detailed overview of Tourmaline Bio's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Tourmaline Bio (Tourmaline Bio) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tourmaline Bio Inc (NAS:TRML) » Definitions » FCF Yield %
Comparable Companies
CYTK NUVL KRYS CRSP INSM FOLD BPMC IMGN AXSM ACAD OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
27 West 24th Street, Suite 702, New York, NY, USA, 10010
Website
https://www.tourmalinebio.com
Tourmaline Bio Inc is a late-stage clinical biotechnology company driven by its mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune diseases. Its initial product candidate is TOUR006, a fully human monoclonal antibody that selectively binds to interleukin-6 (IL-6), a key proinflammatory cytokine involved in the pathogenesis of many autoimmune and inflammatory disorders. The anti-IL-6 and anti-IL-6 receptor (IL-6R) antibody class (IL-6 class) has over two decades of clinical and commercial experience treating over a million patients with a variety of autoimmune and inflammatory diseases.